NCT00698282
Completed
Phase 1
A Randomised, Placebo-Controlled, Double-Blind, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Doses of AZD1981 in Healthy Male Japanese and Caucasian Subjects
Overview
- Phase
- Phase 1
- Intervention
- AZD1981
- Conditions
- Healthy
- Sponsor
- AstraZeneca
- Enrollment
- 47
- Locations
- 1
- Primary Endpoint
- Adverse events
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy Japanese and Caucasian males
Exclusion Criteria
- •Other clinically relevant disease or disorders
Arms & Interventions
1
Intervention: AZD1981
2
Intervention: AZD1981
3
Intervention: Placebo
Outcomes
Primary Outcomes
Adverse events
Time Frame: All the time
Plasma drug concentration
Time Frame: Every hour
Secondary Outcomes
- Clinical chemistry(day 1 and 9)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic PatientsAsthma PatientsNCT01197794AstraZeneca1,144
Completed
Phase 1
A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral ContraceptivesOral ContraceptivesNCT01110525AstraZeneca28
Completed
Phase 1
A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral DosesHealthy MenNCT00935662AstraZeneca119
Completed
Phase 1
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386Chronic PainNCT00690079AstraZeneca69
Terminated
Phase 1
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551HealthyNCT00860353AstraZeneca90